Abstract
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
Published on 31 October 2018
D Kessler, S MacNeill, D Tallon, G Lewis, T Peters, W Hollingworth, J Round, A Burns, C Chew-Graham, I Anderson, T Shepherd, J Campbell, C Dickens, M Carter, C Jenkinson, U Macleod, H Gibson, S Davies, N Wiles
Health Technology Assessment , 2018
Published on 31 October 2018
D Kessler, S MacNeill, D Tallon, G Lewis, T Peters, W Hollingworth, J Round, A Burns, C Chew-Graham, I Anderson, T Shepherd, J Campbell, C Dickens, M Carter, C Jenkinson, U Macleod, H Gibson, S Davies, N Wiles
Health Technology Assessment , 2018
Original language | English |
---|---|
Type | Expert Commentary |
Media of output | Online |
Publisher | NIHR Signal |
DOIs | |
Publication status | Published - 15 Jan 2019 |